Literature DB >> 25478450

Evaluation of OSSIFI® as Alloplastic Bone Graft Material in Treatment of Periodontal Infrabony Defects.

Sumit Kaushal1, Anoop Kapoor2, Preetinder Singh3, Gulsheen Kochhar1, Nitin Khuller3, Patthi Basavaraj4.   

Abstract

INTRODUCTION: The shift in therapeutic concepts from resection to regeneration has significantly impacted the practice of periodontology. Human studies have revealed that hydroxyapatite bone cement holds great promise as a grafting alloplastic material. AIMS AND
OBJECTIVES: To evaluate the efficacy of OSSIFI(®) (combined beta tricalcium phosphate plus hydroxyapatite) in the treatment of periodontal infrabony defects.
MATERIALS AND METHODS: Ten study subjects were selected and divided into two groups. Group I (PD>7mm) and Group II (PD≤ 7mm). Both Groups I and II were treated by regenerative periodontal surgery using OSSIFI(®) as graft material. Plaque index, gingival index, pocket depth, clinical attachment levels were recorded clinically and bone fill, radiographically, at baseline, three months and six months. RESULTS AND
CONCLUSION: Statistically significant reduction in pocket depth, plaque index, gingival index was seen after six months. There was significant bone fill seen from 3-6months with significant gain in clinical attachment levels.

Entities:  

Keywords:  Bone fill; Bone graft; Osteo-conduction; Periodontium; Regeneration

Year:  2014        PMID: 25478450      PMCID: PMC4253268          DOI: 10.7860/JCDR/2014/8501.5043

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  The use of porous beta-tricalcium phosphate blocks with platelet-rich plasma as an onlay bone graft biomaterial.

Authors:  Kazuaki Tamura; Shuichi Sato; Mamoru Kishida; Shoichi Asano; Masakazu Murai; Koichi Ito
Journal:  J Periodontol       Date:  2007-02       Impact factor: 6.993

2.  Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.

Authors:  Anton Sculean; Péter Windisch; Dóra Szendröi-Kiss; Attila Horváth; Péter Rosta; Jürgen Becker; István Gera; Frank Schwarz
Journal:  J Periodontol       Date:  2008-10       Impact factor: 6.993

3.  Mechanism of bone incorporation of beta-TCP bone substitute in open wedge tibial osteotomy in patients.

Authors:  Robert D A Gaasbeek; Hanneke G Toonen; Ronald J van Heerwaarden; Pieter Buma
Journal:  Biomaterials       Date:  2005-11       Impact factor: 12.479

4.  A clinical evaluation of hydroxyapatite cement in the treatment of Class III furcation defects.

Authors:  R D Rupprecht; G M Horning; H J Towle
Journal:  J Periodontol       Date:  2001-10       Impact factor: 6.993

5.  Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.

Authors:  Ferenc Döri; Nicole Arweiler; István Gera; Anton Sculean
Journal:  J Periodontol       Date:  2005-12       Impact factor: 6.993

6.  Histological evaluation of human intrabony periodontal defects treated with an unsintered nanocrystalline hydroxyapatite paste.

Authors:  Attila Horváth; Andreas Stavropoulos; Péter Windisch; László Lukács; István Gera; Anton Sculean
Journal:  Clin Oral Investig       Date:  2012-05-03       Impact factor: 3.573

7.  Synthetic, pure-phase beta-tricalcium phosphate ceramic granules (Cerasorb) for bone regeneration in the reconstructive surgery of the jaws.

Authors:  H-H Horch; R Sader; C Pautke; A Neff; H Deppe; A Kolk
Journal:  Int J Oral Maxillofac Surg       Date:  2006-05-09       Impact factor: 2.789

8.  Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors.

Authors:  Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Naoki Kondo; Wenguang Gu; Takeshi Kamura; Naoto Endo
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2005-01-15       Impact factor: 3.368

9.  Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of human periodontal bony defects--a randomized controlled clinical trial: 6-month results.

Authors:  Adrian Kasaj; Bernd Röhrig; Gregory-George Zafiropoulos; Brita Willershausen
Journal:  J Periodontol       Date:  2008-03       Impact factor: 6.993

10.  Clinical evaluation of a biphasic calcium phosphate grafting material in the treatment of human periodontal intrabony defects.

Authors:  Min-Jae Lee; Byung-Ock Kim; Sang-Joun Yu
Journal:  J Periodontal Implant Sci       Date:  2012-08-31       Impact factor: 2.614

View more
  1 in total

1.  Biphasic Calcium Phosphate Versus Demineralized Freeze-Dried Bone Allograft in the Treatment of Periodontal Disease: A Clinical and Radiographical Evaluation.

Authors:  Santosh Kumar; Nahid Desai; Surabhi Joshi; Tanvi Hirani; Shreya Gajjar; Chandni Patel; Sushmita R Bhakkand; Gaurav A Girdhar; Sharaschandra R Govindool; Wan Farizatul Shima Wan Ahmad Fakuradzi; Mainul Haque
Journal:  Cureus       Date:  2022-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.